Systems medicine: the future of medical genomics and healthcare

被引:233
作者
Auffray, Charles [1 ,2 ]
Chen, Zhu [3 ]
Hood, Leroy [4 ]
机构
[1] CNRS, LGN UMR 7091, F-94801 Villejuif, France
[2] Univ Paris 06, F-94801 Villejuif, France
[3] Jiao Tong Univ, Ctr Syst Biomed, Shanghai 200240, Peoples R China
[4] Inst Syst Biol, Seattle, WA 98103 USA
关键词
DATA INTEGRATION METHODOLOGY; SCALE RELATIVITY THEORY; GENE-EXPRESSION; WIDE ASSOCIATION; TOP-DOWN; FUNCTIONAL GENOMICS; MOLECULAR NETWORKS; REGULATORY NETWORK; OXIDATIVE STRESS; LUNG-CANCER;
D O I
10.1186/gm2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
High-throughput technologies for DNA sequencing and for analyses of transcriptomes, proteomes and metabolomes have provided the foundations for deciphering the structure, variation and function of the human genome and relating them to health and disease states. The increased efficiency of DNA sequencing opens up the possibility of analyzing a large number of individual genomes and transcriptomes, and complete reference proteomes and metabolomes are within reach using powerful analytical techniques based on chromatography, mass spectrometry and nuclear magnetic resonance. Computational and mathematical tools have enabled the development of systems approaches for deciphering the functional and regulatory networks underlying the behavior of complex biological systems. Further conceptual and methodological developments of these tools are needed for the integration of various data types across the multiple levels of organization and time frames that are characteristic of human development, physiology and disease. Medical genomics has attempted to overcome the initial limitations of genome-wide association studies and has identified a limited number of susceptibility loci for many complex and common diseases. Iterative systems approaches are starting to provide deeper insights into the mechanisms of human diseases, and to facilitate the development of better diagnostic and prognostic biomarkers for cancer and many other diseases. Systems approaches will transform the way drugs are developed through academy-industry partnerships that will target multiple components of networks and pathways perturbed in diseases. They will enable medicine to become predictive, personalized, preventive and participatory, and, in the process, concepts and methods from Western and oriental cultures can be combined. We recommend that systems medicine should be developed through an international network of systems biology and medicine centers dedicated to inter-disciplinary training and education, to help reduce the gap in healthcare between developed and developing countries.
引用
收藏
页数:11
相关论文
共 244 条
[91]   From molecular to modular cell biology [J].
Hartwell, LH ;
Hopfield, JJ ;
Leibler, S ;
Murray, AW .
NATURE, 1999, 402 (6761) :C47-C52
[92]   Approaches to dimensionality reduction in proteomic biomarker studies [J].
Hilario, Melanie ;
Kalousis, Alexandros .
BRIEFINGS IN BIOINFORMATICS, 2008, 9 (02) :102-118
[93]   Human protein atlas and the use of microarray technologies [J].
Hober, S. ;
Uhlen, M. .
CURRENT OPINION IN BIOTECHNOLOGY, 2008, 19 (01) :30-35
[94]   Human metabolic phenotype diversity and its association with diet and blood pressure [J].
Holmes, Elaine ;
Loo, Ruey Leng ;
Stamler, Jeremiah ;
Bictash, Magda ;
Yap, Ivan K. S. ;
Chan, Queenie ;
Ebbels, Tim ;
De Iorio, Maria ;
Brown, Ian J. ;
Veselkov, Kirill A. ;
Daviglus, Martha L. ;
Kesteloot, Hugo ;
Ueshima, Hirotsugu ;
Zhao, Liancheng ;
Nicholson, Jeremy K. ;
Elliott, Paul .
NATURE, 2008, 453 (7193) :396-U50
[95]   The impact of systems approaches on biological problems in drug discovery [J].
Hood, L ;
Perlmutter, RM .
NATURE BIOTECHNOLOGY, 2004, 22 (10) :1215-1217
[96]   Systems biology and new technologies enable predictive and preventative medicine [J].
Hood, L ;
Heath, JR ;
Phelps, ME ;
Lin, BY .
SCIENCE, 2004, 306 (5696) :640-643
[97]   Gene regulatory networks and embryonic specification [J].
Hood, Leroy .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (16) :5951-5952
[98]  
Hood Leroy, 2008, Briefings in Functional Genomics & Proteomics, V7, P239, DOI 10.1093/bfgp/eln027
[99]   Cancer: A systems biology disease [J].
Hornberg, JJ ;
Bruggeman, FJ ;
Westerhoff, HV ;
Lankelma, J .
BIOSYSTEMS, 2006, 83 (2-3) :81-90
[100]   The systems biology markup language (SBML):: a medium for representation and exchange of biochemical network models [J].
Hucka, M ;
Finney, A ;
Sauro, HM ;
Bolouri, H ;
Doyle, JC ;
Kitano, H ;
Arkin, AP ;
Bornstein, BJ ;
Bray, D ;
Cornish-Bowden, A ;
Cuellar, AA ;
Dronov, S ;
Gilles, ED ;
Ginkel, M ;
Gor, V ;
Goryanin, II ;
Hedley, WJ ;
Hodgman, TC ;
Hofmeyr, JH ;
Hunter, PJ ;
Juty, NS ;
Kasberger, JL ;
Kremling, A ;
Kummer, U ;
Le Novère, N ;
Loew, LM ;
Lucio, D ;
Mendes, P ;
Minch, E ;
Mjolsness, ED ;
Nakayama, Y ;
Nelson, MR ;
Nielsen, PF ;
Sakurada, T ;
Schaff, JC ;
Shapiro, BE ;
Shimizu, TS ;
Spence, HD ;
Stelling, J ;
Takahashi, K ;
Tomita, M ;
Wagner, J ;
Wang, J .
BIOINFORMATICS, 2003, 19 (04) :524-531